Sadhana Nitrochem Limited has informed the Exchange regarding Outcome of Board Meeting held on May 02, 2025.
SADHNANIQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved audited standalone and consolidated financial results for FY25 (ended March 31, 2025) along with an unmodified audit opinion from Jayesh Dadia & Associates LLP. On a standalone basis, revenue from operations fell sharply by ~29% YoY to Rs. 133.37 crore, and PAT declined ~30% to Rs. 5.22 crore (EPS of Rs. 0.16 vs Rs. 0.30). However, on a consolidated basis, PAT grew ~85% YoY to Rs. 7.56 crore even though revenue dipped ~13% to Rs. 165.55 crore, helped by subsidiary performance. The board recommended a 10% dividend (Rs. 0.10 per share of face value Re. 1) subject to shareholder approval, and confirmed that the entire Rs. 20.39 crore raised via rights issue has been utilised for the stated objects. Statutory, internal, cost, and secretarial auditors were appointed/re-appointed for FY26.
Modest dividend provides some shareholder return, but the sharp standalone revenue and profit decline is a concern. Consolidated PAT growth offers a partial cushion. Auditor continuity and clean audit opinion are positive for governance confidence.